BPC-157 Safety Concerns Human safety data for BPC-157 remain limited
Eggs, especially the yolks, also provide B12
This origin should be understood as a biochemical research background, not as evidence of clinical use, consumer suitability, or therapeutic validation
Drug-specific variables that may affect half-life Drug formulation (ie, modified or controlled release preparations extend half-life) How the drug behaves in the body (ie, zero-order, first-order, or multi-compartmental pharmacokinetics) How the drug is administered (half-life may be different with IV administration, compared to intranasal or oral administration) How the drug is cleared from the body (eg, kidneys, liver, lungs) If the drug accumulates in fat or other types of tissue If the drug binds to proteins or not Presence of metabolites or other drugs that may interact Properties of the drug, including molecule size, charge, and pKa The volume of distribution of a drug Other variables, such as if the drug is actively transported, is self-induced, or has saturation pharmacokinetics
However, if you have digestive issues, your stomach and intestines may not absorb enough of the vitamin to be effective
